EyePoint, Inc. (EYPT)
NASDAQ: EYPT · Real-Time Price · USD
14.72
-0.12 (-0.81%)
At close: Jul 10, 2026, 4:00 PM EDT
14.96
+0.24 (1.61%)
After-hours: Jul 10, 2026, 7:15 PM EDT
EyePoint Market Cap
EyePoint has a market cap or net worth of $1.23 billion as of July 10, 2026. Its market cap has increased by 70.16% in one year.
Market Cap
1.23B
Enterprise Value
1.03B
1-Year Change
70.16%
Ranking
Category
Stock Price
$14.72
Market Cap Chart
Since January 27, 2005, EyePoint's market cap has increased from $388.60M to $1.23B, an increase of 217.59%. That is a compound annual growth rate of 5.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 1.23B | -18.41% |
| Dec 31, 2025 | 1.51B | 197.44% |
| Dec 31, 2024 | 508.50M | -37.68% |
| Dec 29, 2023 | 816.00M | 583.99% |
| Dec 30, 2022 | 119.30M | -66.13% |
| Dec 31, 2021 | 352.20M | 273.09% |
| Dec 31, 2020 | 94.40M | -43.68% |
| Dec 31, 2019 | 167.60M | -6.53% |
| Dec 31, 2018 | 179.30M | 266.67% |
| Dec 29, 2017 | 48.90M | -16.27% |
| Dec 30, 2016 | 58.40M | -58.82% |
| Dec 31, 2015 | 141.80M | 17.58% |
| Dec 31, 2014 | 120.60M | 12.71% |
| Dec 31, 2013 | 107.00M | 279.43% |
| Dec 31, 2012 | 28.20M | 22.08% |
| Dec 30, 2011 | 23.10M | -75.61% |
| Dec 31, 2010 | 94.70M | 44.14% |
| Dec 31, 2009 | 65.70M | 281.98% |
| Dec 31, 2008 | 17.20M | -70.19% |
| Dec 31, 2007 | 57.70M | -25.93% |
| Dec 29, 2006 | 77.90M | -62.73% |
| Dec 30, 2005 | 209.00M | -46.22% |
| Jan 27, 2005 | 388.60M | - |
View and export this data all the way back to 2005. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Corvus Pharmaceuticals | 1.32B |
| Ardelyx | 1.30B |
| First Tracks Biotherapeutics | 1.26B |
| MannKind | 1.26B |
| Capricor Therapeutics | 1.25B |
| Avalyn Pharma | 1.24B |
| Jade Biosciences | 1.24B |
| MeiraGTx Holdings | 1.24B |